Selected article for: "baseline characteristic and significant difference"
Author: Fu, Yue-Qiang; Sun, Yue-Lin; Lu, Si-Wei; Yang, Yang; Wang, Yi; Xu, Feng
Title: Effect of blood analysis and immune function on the prognosis of patients with COVID-19
  • Cord-id: ocyaqs1y
  • Document date: 2020_10_30
    • ID: ocyaqs1y
    Snippet: INTRODUCTION: This retrospective study investigated the implications of changes in blood parameters and cellular immune function in patients with Coronavirus Disease 2019 (COVID-19). METHODS: Records were reviewed of 85 patients admitted with COVID-19 between February 4 and 16, 2020. The primary outcome was in-hospital death. RESULTS: Fourteen patients died. The baseline leukocyte count, neutrophil count and hemoglobin was significantly higher in non-survivors compared with survivors, while the
    Document: INTRODUCTION: This retrospective study investigated the implications of changes in blood parameters and cellular immune function in patients with Coronavirus Disease 2019 (COVID-19). METHODS: Records were reviewed of 85 patients admitted with COVID-19 between February 4 and 16, 2020. The primary outcome was in-hospital death. RESULTS: Fourteen patients died. The baseline leukocyte count, neutrophil count and hemoglobin was significantly higher in non-survivors compared with survivors, while the reverse was true of lymphocyte count, platelet, PaO(2)/FiO(2), CD3+ count and CD4+ count. The percentage of neutrophil count > 6.3×10(9)/L in death group was significantly higher than that in survival group, and multivariate logistic regression showed neutrophil count > 6.3×10(9)/L was independently associated with mortality. However, there were not significant difference in IgG, IgM, IgA, C3, C4 and the percentage of IgE > 100 IU/ml between the death group and survival group. Areas under the receiver operating characteristic curves of the following at baseline could significantly predict mortality: leukocyte, neutrophil, lymphocyte, CD3+ and CD4+ counts. CONCLUSIONS: For hospitalized patients with COVID-19, lymphocyte, CD3+ and CD4+ counts that marked decrease suggest a poor outcome. Admission neutrophil count > 6.3 ×10(9)/L is independently associated with mortality. At admission, leukocyte, neutrophil, lymphocyte, CD3+ and CD4+ counts should receive added attention.

    Search related documents:
    Co phrase search for related documents
    • absolute count and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • absolute count and admission blood: 1, 2, 3, 4, 5, 6, 7
    • absolute count and admission count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • absolute count and admission lymphocyte: 1, 2, 3, 4, 5
    • absolute count and admission neutrophil: 1, 2, 3, 4, 5
    • absolute count and admission onset: 1, 2
    • absolute count and admission patient: 1, 2, 3, 4
    • accompany disease and acute respiratory syndrome: 1, 2
    • acute phase and admission blood: 1, 2, 3, 4, 5
    • acute phase and admission compare: 1
    • acute phase and admission count: 1
    • acute phase and admission onset: 1, 2
    • acute phase and admission patient: 1, 2, 3
    • acute respiratory syndrome and admission leukocyte count: 1, 2
    • acute respiratory syndrome and admission lymphocyte: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and admission neutrophil: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory syndrome and admission onset: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and admission onset interval: 1, 2, 3, 4, 5
    • acute respiratory syndrome and admission patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25